Common complications after cardiac surgery in the adult: Anecdotes, biases... and some evidence

Current Anaesthesia and Critical Care

Volumn 16, Issue 6, 2005, Pages 331-345

  Foot, Carole L ^a   Fraser, John F ^a   Mullany, Daniel V ^a  

^a THE PRINCE CHARLES HOSPITAL   (Australia)

Author keywords

Cardiac surgery; Low cardiac output; Peri operative complications

Indexed keywords

ADRENALIN; AMINOCAPROIC ACID; AMIODARONE; ANTIBIOTIC AGENT; APROTININ; CALCIUM CHANNEL BLOCKING AGENT; DESMOPRESSIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOBUTAMINE; DOPAMINE; ESMOLOL; GLYCEROL NITRATE; HEMOSTATIC AGENT; HEPARIN; HYDRALAZINE; METARAMINOL; METHYLENE BLUE; METOPROLOL; MIDAZOLAM; MILRINONE; NITROPRUSSIDE SODIUM; NORADRENALIN; PHENYLEPHRINE; PROPOFOL; PROTAMINE; RECOMBINANT BLOOD CLOTTING FACTOR 7A; TRANEXAMIC ACID; UNINDEXED DRUG; VASOPRESSIN;

ACALCULOUS CHOLECYSTITIS; ACUTE KIDNEY FAILURE; ACUTE LUNG INJURY; ADULT; ANEMIA; ARTICLE; ATELECTASIS; BLOOD PRESSURE REGULATION; BRADYCARDIA; BRAIN DISEASE; BRONCHOSPASM; CAPILLARY LEAK SYNDROME; CARDIOPULMONARY BYPASS; CARDIOVASCULAR DISEASE; CENTRAL VENOUS PRESSURE; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; DRUG HALF LIFE; ENDOCARDITIS; FATALITY; HEART ARRHYTHMIA; HEART HEMODYNAMICS; HEART MUSCLE ISCHEMIA; HEART OUTPUT; HEART SURGERY; HEART TAMPONADE; HEART VALVE PROSTHESIS; HEART VENTRICLE FAILURE; HEPARIN INDUCED THROMBOCYTOPENIA; HEPATITIS; HUMAN; HYPERGLYCEMIA; HYPERKALEMIA; HYPERTENSION; HYPERTHERMIA; HYPOKALEMIA; HYPOMAGNESEMIA; HYPOTHERMIA; HYPOVENTILATION; INTENSIVE CARE; LUNG EDEMA; LUNG EMBOLISM; MEAN ARTERIAL PRESSURE; NERVE INJURY; NONHUMAN; PANCREATITIS; PARALYTIC ILEUS; PEPTIC ULCER; PLEURA EFFUSION; PNEUMONIA; PNEUMOTHORAX; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE NAUSEA AND VOMITING; POSTOPERATIVE PAIN; PRIORITY JOURNAL; PROSTHESIS FAILURE; SEPSIS; SINGLE DRUG DOSE; TACHYCARDIA; THROMBOCYTOPENIA; TRANSIENT ISCHEMIC ATTACK; URINARY TRACT INFECTION; WOUND INFECTION;

EID: 33745714444     PISSN: 09537112     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cacc.2006.02.001     Document Type: Article

References (75)

1. Kirklin J.K. Prospects for understanding and eliminating the deleterious effects of cardiopulmonary bypass. Ann Thorac Surg 51 4 (1991) 529-531
2. Whitlock R., Crowther M.A., and Ng H.J. Bleeding in cardiac surgery: its prevention and treatment-an evidence-based review. Crit Care Clin 21 3 (2005) 589-610
3. Surgenor D.M., Wallace E.L., Churchill W.H., Hao S.H., Chapman R.H., and Collins Jr. J.J. Red cell transfusions in coronary artery bypass surgery (DRGs 106 and 107). Transfusion 32 5 (1992) 458-464 [Erratum in: Transfusion 1992 Nov-Dec;32(9):876]
4. Unsworth-White M.J., Herriot A., Valencia O., Poloniecki J., Smith E.E., et al. Resternotomy for bleeding after cardiac operation: a marker for increased morbidity and mortality. Ann Thorac Surg 59 3 (1995) 664-667
5. Daily P.O., Lamphere J.A., Dembitsky W.P., Adamson R.M., and Dans N.F. Effect of prophylactic epsilon-aminocaproic acid on blood loss and transfusion requirements in patients undergoing first-time coronary artery bypass grafting. A randomized, prospective, double-blind study. J Thorac Cardiovasc Surg 108 1 (1994) 99-106 [discussion 106-8]
6. Katsaros D., Petricevic M., Snow N.J., Woodhall D.D., and Van Bergen R. Tranexamic acid reduces postbypass blood use: a double-blinded, prospective, randomized study of 210 patients. Ann Thorac Surg 61 4 (1996) 1131-1135
7. Harder M.P., Eijsman L., Roozendaal K.J., van Oeveren W., and Wildevuur C.R. Aprotinin reduces intraoperative and postoperative blood loss in membrane oxygenator cardiopulmonary bypass. Ann Thorac Surg 51 6 (1991) 936-941
8. Bauhut B.F., Harringer W.F., Bettelheim P.F., et al. Comparison of the effects of aprotinin and tranexamic acid on blood loss and related variables after cardiopulmonary bypass. J Thorac Cardiovasc Surg 108 (1994) 108-1091
9. Shore-Lesserson L., Reich D.L., Vela-Cantos F., Ammar T., and Ergin M.A. Tranexamic acid reduces transfusions and mediastinal drainage in repeat cardiac surgery. Anesth Analg 83 1 (1996) 18-26
10. Harder S., Klinkhardt U., and Alvarez J.M. Avoidance of bleeding during surgery in patients receiving anticoagulant and/or antiplatelet therapy: pharmacokinetic and pharmacodynamic considerations. Clin Pharmacokinet 43 14 (2004) 963-981
11. Ilabaca P.A., Ochsner J.L., and Mills N.L. Positive end-expiratory pressure in the management of the patient with a postoperative bleeding heart. Ann Thorac Surg 30 3 (1980) 281-284
12. Murphy D.A., Finlayson D.C., Craver J.M., Jones E.L., Kopel M., Tobia V., et al. Effect of positive end-expiratory pressure on excessive mediastinal bleeding after cardiac operations. A controlled study. J Thorac Cardiovasc Surg 85 6 (1983) 864-869
13. Hackmann T., Gascoyne R.D., Naiman S.C., Growe G.H., Burchill L.D., Jamieson W.R., et al. A trial of desmopressin (1-desamino-8-d-arginine vasopressin) to reduce blood loss in uncomplicated cardiac surgery. N Engl J Med 321 21 (1989) 1437-1443
14. Ghorashian S., and Hunt B.J. "Off-license" use of recombinant activated factor VII. Blood Rev 18 4 (2004) 245-259
15. Franchini M., Zaffanello M., and Veneri D. Recombinant factor VIIa. An update on its clinical use. Thromb Haemost 93 6 (2005) 1027-1035
16. Herbertson M. Recombinant activated factor VII in cardiac surgery. Blood Coagul Fibrinolysis 15 Suppl 1 (2004) S31-S32
17. Watts D.D., Trask A., Soeken K., Perdue P., Dols S., and Kaufmann C. Hypothermic coagulopathy in trauma: effect of varying levels of hypothermia on enzyme speed, platelet function, and fibrinolytic activity. J Trauma 44 5 (1998) 846-854
18. Martini W.Z., Pusateri A.E., Uscilowicz J.M., Delgado A.V., and Holcomb J.B. Independent contributions of hypothermia and acidosis to coagulopathy in swine. J Trauma 58 5 (2005) 1002-1009 [discussion 1009-10]
19. James M.F., and Roche A.M. Dose-response relationship between plasma ionized calcium concentration and thrombelastography. J Cardiothorac Vasc Anesth 18 5 (2004) 581-586
20. Longmore M., Wilkinson I., and Torok E. Oxford handbook of clinical medicine. 5th ed (2001), Oxford University Press, Oxford [p. 142]
21. Morgan T.J. Haemodynamic monitoring. In: Berston A.D., Soni N., and Oh T.E. (Eds). Oh's intensive care manual. 5th ed (2003), Butterworth Heinemann, London 79-94
22. Larose E., Ducharme A., Mercier L.A., Pelletier G., Harel F., and Tardif J.C. Prolonged distress and clinical deterioration before pericardial drainage in patients with cardiac tamponade. Can J Cardiol 16 3 (2000) 331-336
23. Russo A.M., O'Connor W.H., and Waxman H.L. Atypical presentations and echocardiographic findings in patients with cardiac tamponade occurring early and late after cardiac surgery. Chest 104 1 (1993) 71-78
24. Masetti P., Murphy S.F., and Kouchoukos N.T. Vasopressin therapy for vasoplegic syndrome following cardiopulmonary bypass. J Card Surg 17 6 (2002) 485-489
25. Albright T.N., Zimmerman M.A., and Selzman C.H. Vasopressin in the cardiac surgery intensive care unit. Am J Crit Care 11 4 (2002) 326-330 [quiz 331-2. Review. Erratum in: Am J Crit Care 2002 11(6):503]
26. Carrel T., Englberger L., Mohacsi P., Neidhart P., and Schmidli J. Low systemic vascular resistance after cardiopulmonary bypass: incidence, etiology, and clinical importance. J Card Surg 15 5 (2000) 347-353
27. Mekontso-Dessap A., Houel R., Soustelle C., Kirsch M., Thebert D., and Loisance D.Y. Risk factors for post-cardiopulmonary bypass vasoplegia in patients with preserved left ventricular function. Ann Thorac Surg 71 5 (2001) 1428-1432
28. Argenziano M., Chen J.M., Choudhri A.F., Cullinane S., Garfein E., Weinberg A.D., et al. Management of vasodilatory shock after cardiac surgery: identification of predisposing factors and use of a novel pressor agent. J Thorac Cardiovasc Surg 116 6 (1998) 973-980
29. Myles P.S., Leong C.K., and Currey J. Endogenous nitric oxide and low systemic vascular resistance after cardiopulmonary bypass. J Cardiothorac Vasc Anesth 11 5 (1997) 571-574
30. Morales D.L., Garrido M.J., Madigan J.D., Helman D.N., Faber J., Williams M.R., et al. A double-blind randomized trial: prophylactic vasopressin reduces hypotension after cardiopulmonary bypass. Ann Thorac Surg 75 3 (2003) 926-930
31. Levin R.L., Degrange M.A., Bruno G.F., Del Mazo C.D., Taborda D.J., Griotti J.J., et al. Methylene blue reduces mortality and morbidity in vasoplegic patients after cardiac surgery. Ann Thorac Surg 77 2 (2004) 496-499
32. Mayr V.D., Wenzel V., Muller T., Antretter H., Rheinberger K., Lindner K.H., et al. Effects of vasopressin on left anterior descending coronary artery blood flow during extremely low cardiac output. Resuscitation 62 2 (2004) 229-235
33. Knotzer H., Pajk W., Maier S., Ladurner R., Kleinsasser A., Wenzel V., et al. Arginine vasopressin reduces intestinal oxygen supply and mucosal tissue oxygen tension. Am J Physiol Heart Circ Physiol 289 1 (2005) H168-H173
34. Ly H.Q., Greiss I., Talakic M., Guerra P.G., Macle L., Thibault B., et al. Sudden death and hypertrophic cardiomyopathy: a review. Can J Cardiol 21 5 (2005) 441-448
35. Madu E.C., Brown R., and Geraci S.A. Dynamic left ventricular outflow tract obstruction in critically ill patients: role of transesophageal echocardiography in therapeutic decision making. Cardiology 88 3 (1997) 292-295
36. Auer J., Berent R., Weber T., Lamm G., and Eber B. Catecholamine therapy inducing dynamic left ventricular outflow tract obstruction. Int J Cardiol 101 2 (2005) 325-328
37. Aurigemma G., Battista S., Orsinelli D., Sweeney A., Pape L., and Cuenoud H. Abnormal left ventricular intracavitary flow acceleration in patients undergoing aortic valve replacement for aortic stenosis. A marker for high postoperative morbidity and mortality. Circulation 86 3 (1992) 926-936
38. Tasca G., Amaducci A., Parrella P.V., Troise G., Dalla Tomba M., Magna Z., et al. Myectomy-myotomy associated with aortic valve replacement for aortic stenosis: effects on left ventricular mass regression. Ital Heart J 4 12 (2003) 865-871
39. Morewood G.H., and Weiss S.J. Intra-aortic balloon pump associated with dynamic left ventricular outflow tract obstruction after valve replacement for aortic stenosis. J Am Soc Echocardiogr 13 3 (2000) 229-231
40. Lehtonen L.A., Antila S., and Pentikainen P.J. Pharmacokinetics and pharmacodynamics of intravenous inotropic agents. Clin Pharmacokinet 43 3 (2004) 187-203
41. Marenzi G., Lauri G., Grazi M., Assanelli E., Campodonico J., and Agostoni P. Circulatory response to fluid overload removal by extracorporeal ultrafiltration in refractory congestive heart failure. J Am Coll Cardiol 38 4 (2001) 963-968
42. Abrams J. Beneficial actions of nitrates in cardiovascular disease. Am J Cardiol 77 13 (1996) 31C-37C
43. Mielniczuk L., and Stevenson L.W. Angiotensin-converting enzyme inhibitors and angiotensin II type I receptor blockers in the management of congestive heart failure patients: what have we learned from recent clinical trials?. Curr Opin Cardiol 20 4 (2005) 250-255
44. Myburgh J.A. Inotropes and vasopressors. In: Berston A.D., Soni N., and Oh T.E. (Eds). Oh's intensive care manual. 5th ed (2003), Butterworth Heinemann, London 841-855
45. Onasch A., Tanzeem A., Isgro F., Boning D., and Strobel G. Effect of intravenous dopamine infusion on plasma concentrations of dopamine and dopamine sulfate in men, during and up to 18 h after infusion. Eur J Clin Pharmacol 55 10 (2000) 755-759
46. Baruch L., Patacsil P., Hameed A., Pina I., and Loh E. Pharmacodynamic effects of milrinone with and without a bolus loading infusion. Am Heart J 141 2 (2001) 266-273
47. Follath F., Cleland J.G., Just H., Papp J.G., Scholz H., Peuhkurinen K., et al. Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial. Lancet 360 9328 (2002) 196-202
48. Cuffe M.S., Califf R.M., Adams Jr. K.F., Benza R., Bourge R., Colucci W.S., et al. Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial. JAMA 287 12 (2002) 1541-1547
49. Moiseyev V.S., Poder P., Andrejevs N., Ruda M.Y., Golikov A.P., Lazebnik L.B., et al. Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute myocardial infarction. A randomized, placebo-controlled, double-blind study (RUSSLAN). Eur Heart J 23 18 (2002) 1422-1432
50. Apstein C.S., and Lorell B.H. The physiological basis of left ventricular diastolic dysfunction. J Card Surg 3 4 (1988) 475-485
51. Kaddouri S. Chapter 4-Heart failure, myocardium and pericardium. Echo made easy (2002), Churchill Livingstone, UK [p. 88-93]
52. Hochman J.S., Sleeper L.A., Webb J.G., Sanborn T.A., White H.D., Talley J.D., et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK investigators. Should we emergently revascularize occluded coronaries for cardiogenic shock. N Engl J Med 341 9 (1999) 625-634
53. Townsend S.C. Intraartic balloon counterpulsation: principles and review of clinical outcomes. Australasian anaesthesia (2003), Australian and New Zealand College of Anaesthetists 149-162
54. Christenson J.T., Simonet F., Badel P., and Schmuziger M. Optimal timing of preoperative intraaortic balloon pump support in high-risk coronary patients. Ann Thorac Surg 71 (2001) 1400-1401
55. Arafa O.E., Pedersen T.H., Svennevig J.L., Fosse E., and Geiran O.R. Intraaortic balloon pump in open heart operations: 10-year follow-up with risk analysis. Ann Thorac Surg 65 3 (1998) 741-747
56. Baskett R.J., Ghali W.A., Maitland A., and Hirsch G.M. The intraaortic balloon pump in cardiac surgery. Ann Thorac Surg 74 4 (2002) 1276-1287
57. Furnary A.P., Magovern J.A., Simpson K.A., and Magovern G.J. Prolonged open sternotomy and delayed sternal closure after cardiac operations. Ann Thorac Surg 54 2 (1992) 233-239
58. Sulzbach L.M., and Lansdowne L.M. Temporary atrial pacing after cardiac surgery. Focus Crit Care 18 1 (1991) 65 [68-74]
59. Gaudiani V.A., Castro L.J., and Fisher A.L. Biventricular pacing during cardiac operations. Heart Surg Forum 6 6 (2003) E126-E128
60. Jacobs A.K., Leopold J.A., Bates E., Mendes L.A., Sleeper L.A., White H., et al. Cardiogenic shock caused by right ventricular infarction: a report from the SHOCK registry. J Am Coll Cardiol 41 8 (2003) 1273-1279
61. Mebazaa A., Karpati P., Renaud E., and Algotsson L. Acute right ventricular failure-from pathophysiology to new treatments. Intensive Care Med 30 2 (2004) 185-196
62. Zwissler B. Acute right heart failure. Etiology-pathophysiology-diagnosis-therapy. Anaesthesist 49 9 (2000) 788-808 [in German]
63. Loeppky J.A., Scotto P., Riedel C.E., Roach R.C., and Chick T.W. Effects of acid-base status on acute hypoxic pulmonary vasoconstriction and gas exchange. J Appl Physiol 72 5 (1992) 1787-1797
64. Nishida O., Arellano R., Cheng D.C., DeMajo W., and Kavanagh B.P. Gas exchange and hemodynamics in experimental pleural effusion. Crit Care Med 27 3 (1999) 583-587
65. Ahmed S.H., Ouzounian S.P., Dirusso S., Sullivan T., Savino J., and Del Guercio L. Hemodynamic and pulmonary changes after drainage of significant pleural effusions in critically ill, mechanically ventilated surgical patients. J Trauma 57 6 (2004) 1184-1188
66. Roch A., Bojan M., Michelet P., Romain F., Bregeon F., Papazian L., et al. Usefulness of ultrasonography in predicting pleural effusions >500 mL in patients receiving mechanical ventilation. Chest 127 1 (2005) 224-232
67. Schoevaerdts D., Gonzalez M., Evrard P., Buche M., and Installe E. Patent foramen ovale: a cause of significant post-coronary artery bypass grafting morbidity. Cardiovasc Surg 10 6 (2002) 615-617
68. Tabry I., Villanueva L., and Walker E. Patent foramen ovale causing refractory hypoxemia after off-pump coronary artery bypass: a case report. Heart Surg Forum 6 4 (2003) E74-E76
69. Mychaskiw G., Sachdev V., and Heath B.J. Sildenafil (viagra) facilitates weaning of inhaled nitric oxide following placement of a biventricular-assist device. J Clin Anesth 13 3 (2001) 218-220
70. Michelakis E., Tymchak W., Lien D., Webster L., Hashimoto K., and Archer S. Oral sildenafil is an effective and specific pulmonary vasodilator in patients with pulmonary arterial hypertension: comparison with inhaled nitric oxide. Circulation 105 20 (2002) 2398-2403
71. Trachte A.L., Lobato E.B., Urdaneta F., Hess P.J., Klodell C.T., Martin T.D., et al. Oral sildenafil reduces pulmonary hypertension after cardiac surgery. Ann Thorac Surg 79 1 (2005) 194-197 [discussion 194-7]
72. Max M., and Rossaint R. Nitric oxide inhalation in pulmonary hypertension and severe respiratory failure. Curr Opin Cardiol 14 5 (1999) 432-436
73. Welsby I.J., Newman M.F., Phillips-Bute B., Messier R.H., Kakkis E.D., and Stafford-Smith M. Hemodynamic changes after protamine administration: association with mortality after coronary artery bypass surgery. Anesthesiology 102 2 (2005) 308-314
74. Aasbo J.D., Lawrence A.T., Krishnan K., Kim M.H., and Trohman R.G. Amiodarone prophylaxis reduces major cardiovascular morbidity and length of stay after cardiac surgery: a meta-analysis. Ann Intern Med 143 5 (2005) 327-336 [Summary for patients in: Ann Intern Med 2005;143(5):I26]
75. Bradley D., Creswell L.L., Hogue Jr. C.W., Epstein A.E., Prystowsky E.N., Daoud E.G., et al. Pharmacologic prophylaxis: American College of Chest Physicians guidelines for the prevention and management of postoperative atrial fibrillation after cardiac surgery. Chest 128 2 Suppl (2005) 39S-47S